CDK4/6 inhibitors like abemaciclib and ribociclib improve invasive disease-free survival in breast cancer trials, but controversy surrounds study designs, bias, and cost-effectiveness, raising ...

The Breast Reconstruction Market has witnessed remarkable advancements in recent years, driven by medical innovations, a ...

A perfume born from passion for art, empowering jewelry, a fashion capsule, pearls in space, hair care, water with a chef, ...

After ignoring persistent symptoms, I am cancer-free today because I eventually went to the doctor. If my symptoms had faded, ...

The rising rate of colon cancer in young people can't be caused by diet alone, doctors say. Microplastics, sleep, and ...

TrialTranslator represents a significant leap forward in addressing the limitations of traditional clinical trial ...

Here this group designs an abemaciclib-loaded ... responses were seen in four patients. Overall survival in metastatic non-small cell lung cancer is improved by immunotherapy but individual ...

Investing.com -- Shares of OS Therapies, Inc. (NYSE-A: OSTX) surged 58% following the announcement of positive results from its Phase 2b clinical trial for OST-HER2, an immunotherapy candidate ...

A dad-of-three from Co Down was diagnosed with stomach cancer after a year of subtle symptoms. Now cancer-free, he is urging ...

Although comorbidity burden had no prognostic significance in patients with HCC, older age was significantly associated with worse overall survival.